rxstat › Shortages › Fenofibrate

Fenofibrate shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Fenofibrate has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 22
Reports on file
72

Reports by product

Resolved
SANDOZ FENOFIBRATE E
48.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390698 · ended Jun 22, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FENOFIBRATE E
48.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390698 · ended Dec 12, 2025 · Delay in shipping of the drug.
Resolved
LIPIDIL EZ
145MG · TABLET · BGP PHARMA ULC
DIN 02269082 · ended Jul 30, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FENOFIBRATE E
145.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390701 · ended May 19, 2025 · Delay in shipping of the drug.
Resolved
SANDOZ FENOFIBRATE E
145.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390701 · ended Mar 24, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FENOFIBRATE E
48.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390698 · ended Mar 24, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-FENOFIBRATE E
145MG · TABLET · SUN PHARMA CANADA INC
DIN 02454696 · ended Jan 30, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FENOFIBRATE E
48.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390698 · ended Jan 27, 2025 · Demand increase for the drug.
Resolved
AA-FENO-SUPER
160MG · TABLET · AA PHARMA INC
DIN 02246860 · ended Sep 4, 2024 · Disruption of the manufacture of the drug.
Resolved
AA-FENO-SUPER
160MG · TABLET · AA PHARMA INC
DIN 02246860 · ended Mar 19, 2024 · Disruption of the manufacture of the drug.
Resolved
AA-FENO-SUPER
100MG · TABLET · AA PHARMA INC
DIN 02246859 · ended Mar 18, 2024 · Disruption of the manufacture of the drug.
Avoided
SANDOZ FENOFIBRATE S
100MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02288044 · ended Dec 31, 2020 · Delay in shipping of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Fenofibrate. Health Canada has 72 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Fenofibrate is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AB).

Recent changes

Common questions

When will Fenofibrate be back in stock in Canada?

Fenofibrate has no active shortage; supply is normal per Health Canada reports.

Why is Fenofibrate in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (lipid modifying agents, plain)

Partial shortageAtorvastatin11 of 64 reported products affected · est. return Jun 1, 2027Partial shortageCholestyramine Resin1 of 4 reported products affected · est. return Oct 3, 2027Partial shortageColestipol1 of 3 reported products affectedPartial shortageEzetimibe4 of 18 reported products affectedPartial shortageFluvastatin1 of 3 reported products affected · est. return Aug 31, 2026Partial shortageGemfibrozil1 of 3 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.